Spec-T Sore Throat/Decongestant Lozenges Drug Interactions
Currently displaying 221 drugs known to have a moderate interaction with Spec-T Sore Throat / Decongestant Lozenges (benzocaine / phenylephrine / phenylpropanolamine).
Moderate interactions with Spec-T Sore Throat / Decongestant Lozenges (benzocaine / phenylephrine / phenylpropanolamine)
Note: Showing generic names only.
A
- acarbose
- acebutolol
- acetohexamide
- albiglutide
- albuterol
- alogliptin
- amifampridine
- aminophylline
- aminosalicylic acid
- amphetamine
- amyl nitrite
- arformoterol
- armodafinil
- atenolol
- atomoxetine
- atropine
- atropine ophthalmic
B
- belladonna
- benztropine
- betaxolol
- betaxolol ophthalmic
- bexagliflozin
- biperiden
- bisoprolol
- bitolterol
- bupivacaine
- bupivacaine liposome
C
- caffeine
- canagliflozin
- carteolol
- carteolol ophthalmic
- carvedilol
- chloroprocaine
- chloroquine
- chlorpromazine
- chlorpropamide
- clidinium
- cyclopentolate ophthalmic
- cyclophosphamide
D
- dapagliflozin
- dapsone
- dapsone topical
- deserpidine
- dexmethylphenidate
- dextroamphetamine
- dicyclomine
- digitoxin
- digoxin
- dobutamine
- dopamine
- doxapram
- doxepin topical
- droxidopa
- dulaglutide
E
F
G
H
I
- ifosfamide
- iloprost
- indacaterol
- indomethacin
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- iobenguane I 123
- ioflupane I 123
- isoetharine
- isoproterenol
- isosorbide
- isosorbide dinitrate
- isosorbide mononitrate
K
L
- labetalol
- levalbuterol
- levobetaxolol ophthalmic
- levobunolol ophthalmic
- levobupivacaine
- levodopa
- levothyroxine
- lidocaine
- linagliptin
- lindane topical
- liothyronine
- liraglutide
- lisdexamfetamine
- lixisenatide
M
- mecamylamine
- mepenzolate
- mephentermine
- mepivacaine
- mesoridazine
- metaproterenol
- metaraminol
- metformin
- methdilazine
- methotrimeprazine
- methoxamine
- methscopolamine
- methyldopa
- methylphenidate
- metipranolol ophthalmic
- metoclopramide
- metoprolol
- midodrine
- miglitol
- modafinil
N
- nadolol
- nateglinide
- nebivolol
- nitric oxide
- nitrofurantoin
- nitroglycerin
- nitroprusside
- nitrous oxide
- norepinephrine
O
P
- penbutolol
- perphenazine
- phenazopyridine
- phenobarbital
- phenytoin
- pindolol
- pioglitazone
- pirbuterol
- polyethylene glycol 3350 with electrolytes
- pramlintide
- primaquine
- procaine
- procaine penicillin
- prochlorperazine
- procyclidine
- promazine
- promethazine
- propantheline
- propiomazine
- propranolol
- pseudoephedrine
Q
R
- racepinephrine
- rasagiline
- rasburicase
- rauwolfia serpentina
- repaglinide
- reserpine
- ritodrine
- ropivacaine
- rosiglitazone
S
- safinamide
- salmeterol
- saxagliptin
- scopolamine
- scopolamine ophthalmic
- selexipag
- semaglutide
- silver nitrate topical
- silver sulfadiazine topical
- sitagliptin
- solriamfetol
- sotagliflozin
- sotalol
- sulfadiazine
- sulfadoxine
- sulfamethizole
- sulfamethoxazole
- sulfasalazine
- sulfisoxazole
T
- tafenoquine
- terbutaline
- tetracaine
- theophylline
- thiethylperazine
- thioridazine
- thyroid desiccated
- timolol
- timolol ophthalmic
- tirzepatide
- tolazamide
- tolbutamide
- treprostinil
- trifluoperazine
- triflupromazine
- trihexyphenidyl
- trimeprazine
- troglitazone
- tropicamide ophthalmic
Spec-T Sore Throat/Decongestant Lozenges alcohol/food interactions
There is 1 alcohol/food interaction with Spec-T Sore Throat / Decongestant Lozenges (benzocaine / phenylephrine / phenylpropanolamine).
Spec-T Sore Throat/Decongestant Lozenges disease interactions
There are 6 disease interactions with Spec-T Sore Throat / Decongestant Lozenges (benzocaine / phenylephrine / phenylpropanolamine) which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.